淡江大學機構典藏:Item 987654321/115993
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 55025/89277 (62%)
Visitors : 10606152      Online Users : 25
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/115993


    Title: Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery
    Authors: Zhi-Fu Wu;Meei-Shyuan Lee;Chih-Shung Wong;Chueng-He Lu;Yuan-Shiou Huang;Kuen-Tze Lin;Yu-Sheng Lou;Chin Lin;Yue-Cune Chang;Hou-Chuan Lai
    Date: 2018-11
    Issue Date: 2019-03-16 12:10:43 (UTC+8)
    Abstract: WHAT WE ALREADY KNOW ABOUT THIS TOPIC:
    WHAT THIS ARTICLE TELLS US THAT IS NEW: BACKGROUND:: Previous research has shown different effects of anesthetics on cancer cell growth. Here, the authors investigated the association between type of anesthetic and patient survival after elective colon cancer surgery.
    METHODS:
    A retrospective cohort study included patients who received elective colon cancer surgery between January 2005 and December 2014. Patients were grouped according to anesthesia received: propofol or desflurane. After exclusion of those who received combined propofol anesthesia with inhalation anesthesia or epidural anesthesia, survival curves were constructed from the date of surgery to death. After propensity matching, univariable and multivariable Cox regression models were used to compare hazard ratios for death. Subgroup analyses were performed for tumor-node-metastasis staging and postoperative metastasis.
    RESULTS:
    A total of 706 patients (307 deaths, 43.5%) with desflurane anesthesia and 657 (88 deaths, 13.4%) with propofol anesthesia were eligible for analysis. After propensity matching, 579 patients remained in each group (189 deaths, 32.6%, in the desflurane group vs. 87, 15.0%, in the propofol group). In the matched analyses, the propofol-treated group had a better survival, irrespective of lower tumor-node-metastasis stage (hazard ratio, 0.22; 95% CI, 0.11 to 0.42; P < 0.001) or higher tumor-node-metastasis stage (hazard ratio, 0.42; 95% CI, 0.32 to 0.55; P < 0.001) and presence of metastases (hazard ratio, 0.67; 95% CI, 0.51 to 0.86; P = 0.002) or absence of metastases (hazard ratio, 0.08; 95% CI, 0.01 to 0.62; P = 0.016). Simple propensity score adjustment produced similar findings.
    CONCLUSIONS:
    Propofol anesthesia for colon cancer surgery is associated with better survival irrespective of tumor-node-metastasis stage.
    Relation: Anesthesiology 129(5), p.932-941
    DOI: 10.1097/ALN.0000000000002357
    Appears in Collections:[Graduate Institute & Department of Mathematics] Journal Article

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML39View/Open
    Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery.pdf428KbAdobe PDF0View/Open

    All items in 機構典藏 are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - Feedback